Calderaro Charles III
Chief Technical Officer
Calderaro Charles III has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including RNAM, RNA, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 27, 2026.
On the most recent filing, Calderaro Charles III is listed as Chief Technical Officer at Avidity Biosciences, Inc. Inside the rolling window, Calderaro Charles III reported no open-market purchases and 1 open-market sale totaling $269K in RNA.
Companies traded
Other insiders at RNAM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$269K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Calderaro Charles III made?
Calderaro Charles III has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including RNAM, RNA since 2025.
Which companies does Calderaro Charles III trade?
Calderaro Charles III has filed SEC Form 4 disclosures for 2 companies, including RNAM, RNA.
When was Calderaro Charles III's most recent SEC Form 4 filing?
Calderaro Charles III's most recent SEC Form 4 filing on Tracefour is dated Feb 27, 2026.
What is Calderaro Charles III's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Calderaro Charles III is listed as Chief Technical Officer.
What is Calderaro Charles III's total buy and sell value in the current window?
Inside the rolling retention window, Calderaro Charles III bought $0 and sold $269K based on SEC Form 4 filings.
What was Calderaro Charles III's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,727 RNA shares on 2026-01-07, worth $269K, per SEC Form 4 filings.